Telomerase in bladder cancer: back to a better future?

Eur Urol. 2014 Feb;65(2):370-1. doi: 10.1016/j.eururo.2013.10.019. Epub 2013 Oct 28.

Authors

Dan Theodorescu¹, Thomas R Cech²

Affiliations

¹ Department of Surgery, University of Colorado, Aurora, CO, USA; University of Colorado Comprehensive Cancer Center, Aurora, CO, USA. Electronic address: dan.theodorescu@ucdenver.edu.
² University of Colorado Comprehensive Cancer Center, Aurora, CO, USA; Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, BioFrontiers Institute, University of Colorado, Boulder, CO, USA.

PMID: 24184027
DOI: 10.1016/j.eururo.2013.10.019

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers, Tumor / genetics*
DNA Mutational Analysis*
Female
Genetic Testing / methods*
Humans
Male
Mutation*
Promoter Regions, Genetic*
Telomerase / genetics*
Urinary Bladder Neoplasms / enzymology*
Urinary Bladder Neoplasms / genetics*

Substances

Biomarkers, Tumor
TERT protein, human
Telomerase

Grants and funding